abstract |
The present invention relates to a novel solid form of Enzalutamide. In comparison with the prior art, the new solid form of Enzalutamide in the present invention has one or more improved properties, such as good solubility and dissolution rate, good stability, favorable processing properties, and suitability for solid preparation application. The present invention also relates to a preparation method for the new solid form of Enzalutamide, pharmaceutical compositions thereof and uses thereof in preparing drugs for treating diseases such as metastatic castration-tolerant prostate cancer. |